An Extension Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's Disease
Public ClinicalTrials.gov record NCT05543252. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Dose-Blinded Extension Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of UCB0599 in Study Participants With Parkinson's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to estimate the pharmacodynamic effects of minzasolmin (UCB0599) on brain pathophysiology in Early-start versus Delayed-start participants originally diagnosed with new onset Parkinson's disease.
Study identification
- NCT ID
- NCT05543252
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 428 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 78 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 29, 2022 (Actual)
- Primary completion
- Mar 18, 2025 (Actual)
- Completion
- Mar 25, 2025 (Actual)
- Last update posted
- Apr 2, 2026
2022 – 2025
United States locations
- U.S. sites
- 41
- U.S. states
- 27
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pd0055 50506 | Phoenix | Arizona | 85004-1150 | — |
| Pd0055 50519 | Fountain Valley | California | 92708 | — |
| Pd0055 50385 | Fresno | California | 93710 | — |
| Pd0055 50118 | Los Angeles | California | 90033 | — |
| Pd0055 50531 | Englewood | Colorado | 80113 | — |
| Pd0055 50392 | Danbury | Connecticut | 06810 | — |
| Pd0055 50538 | Farmington | Connecticut | 06030-3805 | — |
| Pd0055 50396 | Boca Raton | Florida | 33486 | — |
| Pd0055 50524 | Bradenton | Florida | 34205 | — |
| Pd0055 50394 | Tampa | Florida | 33613 | — |
| Pd0055 50544 | Augusta | Georgia | 30912-0004 | — |
| Pd0055 50401 | Chicago | Illinois | 60611 | — |
| Pd0055 50310 | Chicago | Illinois | 60612-3863 | — |
| Pd0055 50399 | Winfield | Illinois | 60190 | — |
| Pd0055 50549 | Iowa City | Iowa | 52242 | — |
| Pd0055 50074 | Kansas City | Kansas | 66160-8500 | — |
| Pd0055 50121 | Lexington | Kentucky | 40536-0284 | — |
| Pd0055 50395 | New Orleans | Louisiana | 70121 | — |
| Pd0055 50547 | Baltimore | Maryland | 21287 | — |
| Pd0055 50243 | Boston | Massachusetts | 02114 | — |
| Pd0055 50546 | Worcester | Massachusetts | 01655 | — |
| Pd0055 50386 | Farmington Hills | Michigan | 48334 | — |
| Pd0055 50536 | Saint Paul | Minnesota | 55130 | — |
| Pd0055 50397 | Las Vegas | Nevada | 89123 | — |
| Pd0055 50530 | Stony Brook | New York | 11794 | — |
| Pd0055 50535 | Williamsville | New York | 14221 | — |
| Pd0055 50372 | Cleveland | Ohio | 44121 | — |
| Pd0055 50311 | Cleveland | Ohio | 44195 | — |
| Pd0055 50255 | Columbus | Ohio | 43210-1240 | — |
| Pd0055 50398 | Tulsa | Oklahoma | 74136 | — |
| Pd0055 50084 | Charleston | Oregon | 29425 | — |
| Pd0055 50526 | Philadelphia | Pennsylvania | 19107 | — |
| Pd0055 50543 | Memphis | Tennessee | 38157 | — |
| Pd0055 50113 | Houston | Texas | 77030 | — |
| Pd0055 50525 | Houston | Texas | 77030 | — |
| Pd0055 50400 | San Antonio | Texas | 78229-3900 | — |
| Pd0055 50107 | Burlington | Vermont | 05401 | — |
| Pd0055 50410 | Fairfax | Virginia | 22031 | — |
| Pd0055 50534 | Virginia Beach | Virginia | 23456 | — |
| Pd0055 50292 | Kirkland | Washington | 98034 | — |
| Pd0055 50402 | Crab Orchard | West Virginia | 25827 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 55 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05543252, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 2, 2026 · Synced Oct 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05543252 live on ClinicalTrials.gov.